| Piramal Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 543635 |
NSE Symbol : PPLPHARMA |
P/E(TTM) : 28.37 |
|
ISIN Demat : INE0DK501011 |
Div & Yield% : 0.00 |
EPS(TTM) : 5.82 |
|
Book Value(₹) : 61.26 |
Market Cap(₹Cr) : 21,945.89 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,489.06 | 1,195.81 | 1,127.26 | 969.88 | 1,689.80 | 1,248.32 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,489.06 | 1,195.81 | 1,127.26 | 969.88 | 1,689.80 | 1,248.32 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 183.69 | 96.15 | 201.97 | 180.92 | 39.51 | 24.70 |
| Total Income | 1,672.75 | 1,291.96 | 1,329.23 | 1,150.80 | 1,729.31 | 1,273.02 |
| Total Expenditure | 1,251.28 | 1,055.50 | 1,000.19 | 925.55 | 1,273.22 | 1,028.98 |
| PBIDT | 421.47 | 236.46 | 329.04 | 225.25 | 456.09 | 244.04 |
| Interest | 19.50 | 16.84 | 20.38 | 23.23 | 30.56 | 29.17 |
| PBDT | 401.97 | 219.62 | 308.66 | 202.02 | 425.53 | 214.87 |
| Depreciation | 70.12 | 64.69 | 61.25 | 59.44 | 61.17 | 55.46 |
| Tax | 43.11 | 19.39 | 32.55 | 19.63 | 69.55 | 40.83 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 27.11 | 6.63 | 18.53 | 9.81 | 17.54 | -0.22 |
| Reported Profit After Tax | 261.63 | 128.91 | 196.33 | 113.14 | 277.27 | 118.80 |
| Extra-ordinary Items | -51.70 | -22.42 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 313.33 | 151.33 | 196.33 | 113.14 | 277.27 | 118.80 |
| EPS (Unit Curr.) | 1.97 | 0.97 | 1.48 | 0.85 | 2.09 | 0.90 |
| EPS (Adj) (Unit Curr.) | 1.97 | 0.97 | 1.48 | 0.85 | 2.09 | 0.90 |
| Calculated EPS (Unit Curr.) | 1.97 | 0.97 | 1.48 | 0.85 | 2.09 | 0.90 |
| Calculated EPS (Adj) (Unit Curr.) | 1.97 | 0.97 | 1.48 | 0.85 | 2.09 | 0.90 |
| Calculated EPS (Ann.) (Unit Curr.) | 7.89 | 3.89 | 5.92 | 3.42 | 8.37 | 3.59 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 7.89 | 3.89 | 5.92 | 3.42 | 8.37 | 3.59 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 1,327.16 | 1,325.83 | 1,325.52 | 1,324.82 | 1,324.35 | 1,323.58 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.30 | 19.77 | 29.19 | 23.22 | 26.99 | 19.55 |
| PBDTM(%) | 26.99 | 18.37 | 27.38 | 20.83 | 25.18 | 17.21 |
| PATM(%) | 17.57 | 10.78 | 17.42 | 11.67 | 16.41 | 9.52 |
